Evidence map›Paper›PMID 37172190›Full record

ArticleACS chemical neuroscience2023

ACE2 Receptor and TMPRSS2 Protein Expression Patterns in the Human Brainstem Reveal Anatomical Regions Potentially Vulnerable to SARS-CoV-2 Infection.

Aron Emmi, Aleksandar Tushevski, Alessandro Sinigaglia, Silvia Barbon, Michele Sandre, Elena Stocco, Veronica Macchi, Angelo Antonini, Luisa Barzon, Andrea Porzionato and 1 more

Open access · hybridAbstract read
In one paragraph

Article in ACS chemical neuroscience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Neuroimmune pathophysiology of long COVID.Psychiatry and clinical neurosciences · 2025
    Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Aron EmmiInstitute of Human Anatomy, Department of Neuroscience, University of Padova, 35121 Padova, Italy.ORCID 0000-0002-2796-5676
Aleksandar TushevskiInstitute of Human Anatomy, Department of Neuroscience, University of Padova, 35121 Padova, Italy.
Alessandro SinigagliaDepartment of Molecular Medicine, University of Padova, 35121 Padova, Italy.
Silvia BarbonInstitute of Human Anatomy, Department of Neuroscience, University of Padova, 35121 Padova, Italy.
Michele SandreMovement Disorders Unit, Padova University Hospital, 35121 Padova, Italy.
Elena StoccoInstitute of Human Anatomy, Department of Neuroscience, University of Padova, 35121 Padova, Italy.
Veronica MacchiInstitute of Human Anatomy, Department of Neuroscience, University of Padova, 35121 Padova, Italy.
Angelo AntoniniMovement Disorders Unit, Padova University Hospital, 35121 Padova, Italy.
Luisa BarzonDepartment of Molecular Medicine, University of Padova, 35121 Padova, Italy.
Andrea PorzionatoInstitute of Human Anatomy, Department of Neuroscience, University of Padova, 35121 Padova, Italy.ORCID 0000-0003-3025-4717
Raffaele De CaroInstitute of Human Anatomy, Department of Neuroscience, University of Padova, 35121 Padova, Italy.
University of Padua · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Angiotensin-converting enzyme 2 receptor (ACE2R) is a transmembrane protein expressed in various tissues throughout the body that plays a key role in the regulation of blood pressure. Recently, ACE2R has gained significant attention due to its involvement in the pathogenesis of COVID-19, the disease caused by the Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV-2). While ACE2 receptors serve as entry points for the novel coronavirus, Transmembrane Serine Protease 2 (TMPRSS2), an enzyme located on the cell membrane, is required for SARS-CoV-2 S protein priming. Even though numerous studies have assessed the effects of COVID-19 on the brain, very little information is available concerning the distribution of ACE2R and TMPRSS2 in the human brain, with particular regard to their topographical expression in the brainstem. In this study, we investigated the expression of ACE2R and TMPRSS2 in the brainstem of 18 adult subjects who died due to pneumonia/respiratory insufficiency. Our findings indicate that ACE2R and TMPRSS2 are expressed in neuronal and glial cells of the brainstem, particularly at the level of the vagal nuclei of the medulla and the midbrain tegmentum, thus confirming the expression and anatomical localization of these proteins within specific human brainstem nuclei. Furthermore, our findings help to define anatomically susceptible regions to SARS-CoV-2 infection in the brainstem, advancing knowledge on the neuropathological underpinnings of neurological manifestations in COVID-19.

Indexed as

COVID-19AdultAngiotensin-Converting Enzyme 2Brain StemHumansSARS-CoV-2Serine EndopeptidasesSpike Glycoprotein, CoronavirusAngiotensin-Converting Enzyme 2Serine EndopeptidasesSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2TMPRSS2 protein, humanACE2brainCOVID-19neuropathologySARS-CoV-2TMPRSS2

Identifiers

PMID37172190
PMCPMC10228702
OpenAlexW4376507196

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.